Source: Myeloma : nature.com subject feeds
Post Content
Recent Content
- Durcabtagene Autoleucel Demonstrates Rapid Proliferation and Persistence in Relapsed/Refractory Myeloma
- At Multiple Dose Levels, Mezigdomide Elicits Responses in Combination With Bortezomib or Carfilzomib in R/R Myeloma
- PVd Extends OS and PFS in Relapsed/Refractory Multiple Myeloma
- Systemic Review Sheds Light on Efficacy of Bispecific Antibodies in Extramedullary R/R Multiple Myeloma
- Real-life experience with plasmapheresis in newly diagnosed multiple myeloma accompanied by acute kidney injury
- Health care professionals express support for postpartum depression, myeloma treatments
- Physical Activity Improves Performance, Frailty Scores, and PROs in Multiple Myeloma
- Limited Efficacy Seen With Ixazomib Plus Daratumumab and Low-Dose Dexamethasone in Intermediate-Fit Patients With MM
- Dr Beksac on OS Data From the OPTIMISMM Trial in Relapsed/Refractory Multiple Myeloma
- Dr Leypoldt on the Use of Isa-KRd in Newly Diagnosed, High-Risk Multiple Myeloma